What is the current Peramivir market size?

The Peramivir market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Peramivir market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Peramivir market?

Increasing demand for antiviral medications and rising incidence of influenza drive the market.

What are the challenges facing the Peramivir market?

Stringent regulatory requirements and high development costs pose significant challenges.

Which regions lead the Peramivir market?

North America and Asia Pacific are the leading regions in the Peramivir market.

Who are the top companies in the Peramivir market?

BioCryst Pharmaceuticals and Seqirus are among the top companies in the market.

What are the future opportunities in the Peramivir market?

Emerging markets and increasing use of Peramivir for influenza treatment offer future opportunities.

How does technology impact the Peramivir market?

Advances in drug development and manufacturing technologies improve the future outlook.

What is the regulatory landscape of the Peramivir market?

The market is regulated by authorities such as the FDA and EMA.

What is the expected future outlook of the Peramivir market?

The market is expected to experience significant growth due to increasing demand.

How Big Is the Peramivir Market? Size, Share & Forecast 2033

Peramivir by Application (Influenza A Treatment, Influenza B Treatment), by Types (Solution, Solid), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Peramivir Market Size | CAGR 10.2 Forecast 2033

How Big Is the Peramivir Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Peramivir Market Overview

The Peramivir market refers to the global industry involved in the development, manufacturing, and distribution of Peramivir, an antiviral medication used to treat influenza. As a key player in the pharmaceutical industry, the Peramivir market size is estimated to be around $140 million in 2025. The growth outlook for the Peramivir market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 12% during the forecast period of 2026-2033, driven by increasing demand for effective influenza treatments and industry expansion. The scope of the Peramivir market encompasses various segments, including type, application, and end-user, with a focus on hospital settings, clinics, and research institutions.

Loading chart…

The Peramivir market is driven by key forces such as technological advancements in drug development, regulatory approvals, and consumer behavior shifts towards preventive care. The largest region for the Peramivir market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and a rising demand for effective influenza treatments. As the market continues to evolve, it is essential for industry players to stay informed about the latest trends, challenges, and opportunities to maintain a competitive edge in the Peramivir market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BioCryst Pharmaceuticals; Green Cross Pharma; Shionogi Co.; NeoPharm; Moksha8 Pharma; NT Pharma; Merck; Hikma Pharmaceuticals; Hunan Nucien Pharmaceutical Co.,Ltd.; SCOLR Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Peramivir market is poised for significant growth, driven by increasing demand for effective antiviral treatments. The growth forecast for the Peramivir market size is expected to be substantial, driven by factors such as the rising incidence of influenza and the need for novel therapeutic options.

Growth Drivers2 items

The increasing prevalence of influenza and the growing need for effective treatments are driving the demand for Peramivir, thereby contributing to the growth of the Peramivir market.

Advances in medical technology and the development of novel antiviral agents are expected to further boost the Peramivir market size and drive growth in the forecast period.

Restraints2 items

Stringent regulatory requirements and the high cost of research and development are expected to hinder the growth of the Peramivir market, as companies may be deterred from investing in this space.

The availability of alternative treatments and the risk of antiviral resistance are also expected to restrain the growth of the Peramivir market size in the forecast period.

Opportunities2 items

The growing demand for antiviral treatments in emerging economies presents a significant opportunity for players in the Peramivir market to expand their presence and increase their market share.

The development of novel formulations and delivery systems for Peramivir is expected to provide opportunities for companies to differentiate their products and gain a competitive edge in the Peramivir market.

Challenges2 items

The Peramivir market is highly competitive, with several established players, and new entrants may face challenges in gaining traction and market share.

The growth forecast for the Peramivir market size may be impacted by factors such as pricing pressure, reimbursement issues, and the risk of supply chain disruptions.

Market Segmentation

Loading chart…

The Peramivir market can be segmented based on Application, which includes the treatment of influenza. This segmentation contributes to the overall Peramivir market size by highlighting the specific uses of Peramivir. The application segment is crucial in understanding the Peramivir segmentation and its impact on the market. In the context of Peramivir segmentation, the application segment is divided into subtypes, including treatment of influenza, which holds a significant share of the market.

Another significant segmentation of the Peramivir market is based on Types, which includes subtypes such as intravenous and oral forms. This segmentation is essential in understanding the market taxonomy and the different forms in which Peramivir is administered. The types segment contributes to the overall Peramivir market size by providing insights into the various forms of Peramivir and their respective market shares. The types segment is critical in understanding the Peramivir market and its growth prospects.

Peramivir Segmentation Breakdown6 items

Application

Influenza A Treatment

Influenza B Treatment

Types

Solution

Solid

Regional Insights

Loading chart…

The Peramivir market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, driven by factors such as high adoption rates, favorable policies, and significant investments in healthcare infrastructure. The region's large population, rising demographics, and increasing awareness of antiviral treatments also contribute to its dominance.

North America is the fastest-growing region, with a regional forecast indicating a significant increase in demand for Peramivir, driven by key drivers such as advanced ecosystem maturity, high infrastructure development, and a strong investment landscape. Europe is also expected to experience steady growth, driven by factors such as increasing adoption of antiviral treatments, favorable policies, and a well-established infrastructure. Latin America and Middle East & Africa are expected to experience moderate growth, driven by improving demographics, increasing awareness, and growing investments in healthcare.

Key Drivers by Region5 items

Asia Pacific: high adoption rates, favorable policies, significant investments

North America: advanced ecosystem maturity, high infrastructure development, strong investment landscape

Europe: increasing adoption of antiviral treatments, favorable policies, well-established infrastructure

Latin America: improving demographics, increasing awareness, growing investments in healthcare

Middle East & Africa: rising demographics, increasing adoption, and expanding healthcare infrastructure

Competitive Landscape

The Peramivir market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Peramivir competitive landscape is characterized by high competition, with companies focusing on differentiation through innovation and strategic partnerships. Global players are expanding their presence in emerging markets, while local companies are leveraging their regional strengths to compete.

Companies in the Peramivir market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies are implementing strategic focuses:

BioCryst Pharmaceuticals: regional expansion

Green Cross Pharma: premium pricing

Shionogi Co.: innovation pipeline

NeoPharm: local manufacturing

Moksha8 Pharma: OEM tie-ups

NT Pharma: vertical integration

Key Peramivir Companies10 items

BioCryst Pharmaceuticals

Green Cross Pharma

Shionogi Co.

NeoPharm

Moksha8 Pharma

NT Pharma

Merck

Hikma Pharmaceuticals

Hunan Nucien Pharmaceutical Co.,Ltd.

SCOLR Pharma

Market Ecosystem

The Peramivir ecosystem spans the entire value chain, from upstream technology providers and suppliers to midstream integrators and channels, and finally to downstream end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of Peramivir. The boundaries of this ecosystem are defined by the interactions and relationships between these various participants, influencing how value is created and captured.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs/manufacturers — produce Peramivir formulations

Distributors/channel partners — facilitate product distribution

Service providers/after-sales — offer support and maintenance services

End users/buyers — administer Peramivir to patients

Regulators/standards bodies — establish and enforce safety standards

Data/analytics providers — track usage and efficacy data

In the Peramivir ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through safety and efficacy approvals. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and standards approvals. Switching costs are relatively high due to the need for new formulations to undergo rigorous testing and approval processes. Furthermore, partnerships between manufacturers and distributors are crucial for ensuring timely and widespread product availability. The Peramivir ecosystem differs by region, with varying regulatory requirements and market conditions influencing the value chain analysis.

Recent Industry Insights

The Peramivir industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have been forged to enhance the production and distribution of Peramivir, a key antiviral medication. Notable mergers & acquisitions have also taken place, leading to increased consolidation in the market. Furthermore, several product/technology launches have been announced, focusing on improving the efficacy and administration of Peramivir. Regulatory changes have also impacted the industry, with updated guidelines for the use of Peramivir in treating influenza. A shift in consumer or enterprise trends has been observed, with a growing demand for effective antiviral medications. Additionally, funding rounds or expansions have been secured by key players to support research and development in the Peramivir market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Peramivir market. The Peramivir market outlook is attractive, driven by increasing demand for effective antiviral medications. The competitive intensity is moderate, with a few key players dominating the market. In the long term, the market is expected to grow, driven by innovation in drug development and increasing awareness of infectious diseases.

The innovation landscape is evolving, with a focus on developing more effective and targeted treatments. The demand-supply balance is currently stable, but may be affected by key risk factors such as regulatory changes and patent expirations. Overall, the Peramivir market offers opportunities for growth and investment, but requires careful consideration of these factors to navigate its complexities.

12 items

1. Executive Summary

2. Peramivir Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peramivir Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Peramivir Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Peramivir Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Peramivir Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Peramivir Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Peramivir Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Peramivir Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Peramivir Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Peramivir Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Peramivir Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peramivir Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Peramivir Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Peramivir Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Peramivir Market Competition by Key Manufacturers

9.1. Global Peramivir Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Peramivir: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BioCryst Pharmaceuticals

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Green Cross Pharma

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Shionogi Co.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. NeoPharm

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Moksha8 Pharma

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. NT Pharma

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Merck

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Hikma Pharmaceuticals

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Hunan Nucien Pharmaceutical Co.,Ltd.

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. SCOLR Pharma

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peramivir Market

Figure 4: Global Peramivir Market: Drivers

Figure 5: Global Peramivir Market: Challenges

Figure 6: Global Peramivir Market: Trends

Figure 7: Global Peramivir Market: Opportunity

Figure 8: Global Peramivir Market: Restraint

Figure 9: Global Peramivir Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Peramivir Market Value (USD Million) By Region

Figure 19: Global Peramivir Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Peramivir Market Value (USD Million) By Region

Figure 27: Global Peramivir Market Share (%) By: Regions (2032)

Figure 28: Global Peramivir Market Volume (K) By Region

Figure 29: Global Peramivir Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Peramivir Market Value (USD Million) By Region

Figure 37: Global Peramivir Market Share (%) By: Regions (2032)

Figure 38: Global Peramivir Market Volume (K) By Region

Figure 39: Global Peramivir Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Peramivir Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peramivir Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Peramivir Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Peramivir Market Value (USD Million) By Region

Table 14: Global Peramivir Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Peramivir Market Volume (K) By Region

Table 31: Global Peramivir Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Peramivir Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Peramivir Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Peramivir Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BioCryst Pharmaceuticals Basic Information And Sales Area

Table 52: BioCryst Pharmaceuticals. Products Portfolio

Table 53: Green Cross Pharma Basic Information And Sales Area

Table 54: Green Cross Pharma. Products Portfolio

Table 55: Shionogi Co. Basic Information And Sales Area

Table 56: Shionogi Co.. Products Portfolio

Table 57: NeoPharm Basic Information And Sales Area

Table 58: NeoPharm. Products Portfolio

Table 59: Moksha8 Pharma Basic Information And Sales Area

Table 60: Moksha8 Pharma. Products Portfolio

Table 61: NT Pharma Basic Information And Sales Area

Table 62: NT Pharma. Products Portfolio

Table 63: Merck Basic Information And Sales Area

Table 64: Merck. Products Portfolio

Table 65: Hikma Pharmaceuticals Basic Information And Sales Area

Table 66: Hikma Pharmaceuticals. Products Portfolio

Table 67: Hunan Nucien Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 68: Hunan Nucien Pharmaceutical Co.,Ltd.. Products Portfolio

Table 69: SCOLR Pharma Basic Information And Sales Area

Table 70: SCOLR Pharma. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Peramivir Market Value (USD Million) By Region

Table 80: Global Peramivir Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Peramivir Market Volume (K) By Region

Table 97: Global Peramivir Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Peramivir Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BioCryst Pharmaceuticals; Green Cross Pharma; Shionogi Co.; NeoPharm; Moksha8 Pharma; NT Pharma; Merck; Hikma Pharmaceuticals; Hunan Nucien Pharmaceutical Co.,Ltd.; SCOLR Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options